Medical, Technology/Innovations
Namaste Technologies Inc. (OTCMKTS: NXTTF) announced on June 25th the company has achieved over 6,000 registered users on their NamasteMD app platform. NamasteMD is Namaste Technologies is Canada’s first medical cannabis app for Android and Apple devices. The app...
Medical, Technology/Innovations, Trending
Namaste Technologies Inc. (OTCMKTS: NXTTF) announced on June 25th the company has achieved over 6,000 registered users on their NamasteMD app platform. NamasteMD is Namaste Technologies is Canada’s first medical cannabis app for Android and Apple devices. The app...
Medical, Technology/Innovations
The U.S. Food and Drug Administration (FDA) approved on June 25th the cannabis-derived drug Epidiolex for treatment of seizures that are associated with two forms of epilepsy. Epidiolex is a cannabidiol (CBD) containing drug that does not contain any psychoactive...
Medical, Technology/Innovations, Trending
The U.S. Food and Drug Administration (FDA) approved on June 25th the cannabis-derived drug Epidiolex for treatment of seizures that are associated with two forms of epilepsy. Epidiolex is a cannabidiol (CBD) containing drug that does not contain any...
Expansion, Partnership, Technology/Innovations
Columbia Care, LLC announced on June 21st the company’s entrance into a license agreement with Rhinomed (ASX: RNO) to develop a cannabis product line where the products will be delivered through nasal passageways. Rhinomed is an Australian-based company that...
Expansion, Partnership, Technology/Innovations, Trending
Columbia Care, LLC announced on June 21st the company’s entrance into a license agreement with Rhinomed (ASX: RNO) to develop a cannabis product line where the products will be delivered through nasal passageways. Rhinomed is an Australian-based company that...
